Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. [electronic resource]
Producer: 20140609Description: 1577-90 p. digitalISSN:- 1527-3350
- Animals
- Bile Ducts -- physiopathology
- Carbon Tetrachloride -- adverse effects
- Carcinoma, Hepatocellular -- pathology
- Cell Proliferation -- drug effects
- Cells, Cultured
- Diethylnitrosamine -- adverse effects
- Disease Models, Animal
- Disease Progression
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Hepatic Stellate Cells -- drug effects
- Hepatocytes -- drug effects
- Humans
- Ligation -- adverse effects
- Liver Cirrhosis -- etiology
- Liver Neoplasms -- pathology
- Male
- Mice
- Mice, Inbred Strains
- Phosphorylation -- drug effects
- Prognosis
- Quinazolines -- pharmacology
- Rats
- Rats, Wistar
- Transcriptome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.